Axcelis Beats On Q3 As Bookings Surge To 1.5x Book-To-Bill, But Won-Driven Margin Miss And A Delayed Veeco Close Temper The Recovery Story

Axcelis Technologies delivered the order recovery that skeptics doubted. Non-GAAP earnings of $1.26 per share beat the $1.11 consensus by 8.6% and cleared the $1.16 Earnings Whisper number. Revenue of $237.78 million topped the $230.05 million consensus by 3.4%. The more important number was bookings: $222 million, a 1.5 book-to-bill and the highest level since Q4 2023, up from $131 million in Q2. That pushed backlog to $531 million from $452 million and supports a fourth-quarter guide of roughly $275 million in revenue and $1.50 in non-GAAP EPS, which the company says is above estimates. The central tension is that the cycle is turning up while margins are not yet following.

The quality of the beat is mixed. Revenue grew 11.3% year over year, but non-GAAP EPS grew only 5.9%, and the gap reflects real margin pressure. Non-GAAP gross margin of 41.2% missed the company's own 43% guide and slipped from 42.7% in Q2, which management attributed to Korean won strength. Non-GAAP operating margin fell to 16.6% from 18.2% a year ago as non-GAAP operating expenses rose to $58.5 million from $50.4 million. Higher interest and other income also helped the bottom line.

GAAP EPS jumped to $1.21 from $0.83, but that comparison flatters the quarter. It includes a $0.30 benefit from discrete tax items tied to audits, and the year-ago period carried heavier Veeco transaction costs. Year to date, non-GAAP EPS of $3.04 still trails last year's $3.38, so Q3 is better read as the first quarter of renewed growth than as a recovered earnings base.

The call materially upgraded the demand narrative. Earlier this year, management described general mature as "down in 2026" with no order pickup. That segment produced the largest bookings gain this quarter, driven by AI-related capacity expansion in North America and by Europe. Other drivers also improved:

• Power bookings have risen four straight quarters, helped by silicon carbide pull-ins.
• Memory is heading toward a record DRAM year, with share gains outside Korea.
• CS&I set another record at $93 million.

Management now expects growth in 2027 across memory, power, general mature and CS&I, with Q1 2027 revenue flat with Q4 despite normal CS&I seasonality. Full-year guidance has climbed steadily from flat to an implied roughly $923 million. Free cash flow improved to $38 million from $15 million in Q2. Rising deferred revenue and inventory on the balance sheet are consistent with a business preparing for higher shipments.

Bears still have legitimate ammunition, and most of it sits on the margin line. Fourth-quarter gross margin is guided to only 42.5%, far below the 47.3% posted in Q4 2025, while quarterly operating expenses step up to about $65 million. Management expects 2027 gross margin to exceed 2026. However, the mix is tilting toward lower-margin memory systems and toward systems over CS&I, which complicates that expansion.

Other risks remain:

• **Merger timing:** The Veeco merger close slipped from the second half of 2026 to the end of Q1 2027, with China's SAMR approval pending and an HSR refiling required.
• **Power and competition:** Power remains slightly down year over year, and domestic Chinese implant competitors are emerging.
• **Supply chain:** Component tightness is a watch item for 2027.
• **Disclosure:** Services results are no longer reported separately.

On the positive side, the company announced a $35 million Korean manufacturing facility, won proton implant orders for silicon IGBTs, and named Jeroen Delsman as its new CFO.

The market was not positioned for good news. Shares entered the report at $92.14, down 32.6% since the open following the August report and about 25% below the $123 200-day moving average. They were also just 1.7% above the inter-earnings low of $90.62, set the day before results, after peaking at $149.95 in early October. Investor sentiment slipped from -0.02 to -0.07, a modest move that leaves expectations hovering near neutral rather than deeply bearish. The Earnings Whispers trend readings are split: sequential growth and momentum are positive, while price and AVWAP remain negative. That split mirrors the gap between improving fundamentals and a stock under persistent selling pressure.

The bottom line is that Axcelis produced the clearest evidence yet of a cyclical upturn: surging bookings, a growing backlog, a sharply higher Q4 guide and a broad-based 2027 growth call. Those developments arrived with the stock near its lows. The unresolved questions are whether gross margin can rebuild toward prior levels despite currency headwinds and an unfavorable mix, and whether the Veeco deal closes on its revised schedule. Volume is improving faster than profitability, and that is the gap investors will need to see close.

Read our earnings preview for Axcelis Technologies, Inc.: https://www.earningswhispers.com/article/ACLS/22033

This earnings review was originally published on Earnings Whispers.

This article is for informational purposes only and is not investment advice. Earnings Whispers and its staff may hold positions in the securities mentioned. It is AI-assisted, based on proprietary Earnings Whispers data and company reports, and edited by Earnings Whispers staff.